3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow XK 469: new trials by email Literature Review of XK 469 trials Research Report on XK 469
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| XK469R in Treating Patients With Refractory Hematologic Cancer R(+)XK469, pharmacological study, laboratory biomarker analysis - Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 1 | Completed | National Cancer Institute (NCI) | 60 | 2004-10-01 | 2013-02-08 |
| XK469 in Treating Patients With Advanced Solid Tumors R(+)XK469 - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Barbara Ann Karmanos Cancer Institute | 22 | 2002-01-01 | 2014-04-25 |
| R(+)XK469 in Treating Patients With Advanced Neuroblastoma R(+)XK469 - Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 85 | 2001-12-01 | 2013-12-16 |
Anemia, Refractory, with Excess of Blasts (1) · Blast Crisis (1) · Congenital Abnormalities (1) · Leukemia, Basophilic, Acute (1) · Leukemia, Eosinophilic, Acute (1) · Leukemia, Erythroblastic, Acute (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Neuroblastoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
National Cancer Institute (NCI) (2) · Barbara Ann Karmanos Cancer Institute (1)
United States (3)
Francis Giles (1) · Patricia M. LoRusso, DO (1) · Susan Cohn (1)
P30CA022453 (1), U01CA062487 (1), U01CA069852 (1)